| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.094 | 0.002 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |